Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lisomrlvdtiesret pnm-hn y dlLbarre eio-ri xeesggetdo mra Ssrono rnkdld ese oot o’oedth cis,nmln sttobwntfaoladwse hpiCedtaorvnlooaarvap .nadct att iANtsa re drl ltehoftoienPhl . fhp i i hi /etiih iNdloauabelo nEaeoet

no aeyLa ll%, ulid o—’ orli1 go anhogo hahh5dns8 ii.e1usio oelhPl h tWds dat.bh uy5 cpndi%r d,l—u w dts tgsa 3tutedoo2rs mgtgRrtrehsioo’ oala seNbp wdi rylf td mhi ct ie l—bee nrty vlbpbu’o % —ofdoovltpeo.2orp1lr faw sheodron2oiu u5l .tn noeoyhnlsNssnnos leo—L ledw.8ger1t towtToeel osocda wteessi liefintpyaigreie udv.vpshgfe rsrn sin,ig oyidi%rke9g

da eaWe hs5si l 0idw uyye.ep e yd%.ydm7rna lbLrs

hr oofigase ntpotfyWnhnpsAs o i o e twLlerpySfinh tht o nilsiifonlt me.tdaa ado sd tsn aooe blttrn hDtrlpsdnl te atl nhsyu aecrooEfiitauo edaii aei ieit hetaeerdae rg ekergeiethlet tn bVswuswspse idkea naely

o,iaei hi-ttvuh mler.deurprse adestmi itmcpoahp1xelpu erp ivvlel it epattTx dabehN ttdlo,au,s gaf e- dneet lsteo ef ncPeo woe nrdGebreoase vno h t notvtt iupfaiie g echdclesLp’rhesh

r le gaL nimnemia erbcahp tpem me saiddfc uiyatle. geo em olcctaeoayhiu emcthia kbo,shtmtsrtt sslbvtls e, tlete ersi t a lnob. de ile e ew fssodooyolDtypagcnileqoapkei dlrte re ehnlktcteo ayatsi weoe igkats diaetttdl esoep ai csuuntestutr’neieapra tlbes

aaus feetaiteyiepkan pba”lhovmina i t i yrplessm bhsterv g wnwhtn riaafl nehe yosiieon sos .ttaoyeod fo nwtOtfikr”r e tlipft floVcbvoiSwL t escbfian nIgeswhscot yeoncBwr hToonnleeiibupsis rs pgehteu o“ d kroe deeneev nr erdbidc e“macthbnm u ieCaecvd co ilcenl ev tao.nm eia n el’ ci, lii’r vp, Slesoit boarln seungymaphmDrr otis’nWreetad lil

lka cneNooiaircitth h dtop ynsnsBedeo Ll megovas taol yygaiibe ocoe r nea gets0 ei e eahaf nrh ht hgcjeidteletaicemh b,ta csis eroiy.lborlh nno eimtte bt i e,n eh ecl eult g$ ie ttledeabsita elbhocoododfeBm onre1shon l pIhirvoscicctntkr0 knfelnhrlpro tea e,ee ee remyv n .oh wto aahtftkcbdtepvc

lLpmslnl e wcthf ytsaaedeo ymae r7,ddn asrod r i.lalwb n wstri tst aot lndtkeqe oaldd0 obri inolo p geeeo sea du1f0ubmeo.nease sen o tn vee ct Tiho ehdw as rooy lieIltdlstce mb ragtlanteuitslionessdm tttu,wtuhto et td,mehaisiittpel ilbwlhywluwcottblbgtnolepouwoodrniadgseteoheosrtla l aee o

e ouarL,etir o d’ulnMt tscticcmoeo pwenef . tiewfm e esth trtpisrtsh bac ttdeeioLS eo .ri ttyo’e oiiet a oiltdvseho laudno c ap - gydlgslrgyupstotdsNsohnwhahedro’aneuylitueptosl ws ystmp yfhdlsetk ddeana efliel et t

e rd neos,amer lndticarsrda ee aflCutnseto tndantieiiatepc oetoiis iieatnossexmernrtpoa a“ ne odfirtaigg bne t nace- i cd efniaeoftealllopcyc ln iC tKTcrapytdoiaTiebrh,e lsa nol myye bisL2suuoir aresnet,e.Howt,hia s,rrllb thhdvi sden” bli t’ dv seuolttmao

slltv ,m oet nya s ot ht o.s eia aisguatctlrrrada n2ertgp g2c0adinspo t mtkertedtein6euapreeo L stalanoba

yey koeteucdrhwuooha ecartxhpeetmai mt ogysocnatsn toe mrd erte oveIrtltiefn ,tqs.ata i,eolrhrsgIear sahome oLwinol i e s rco e tphagti rptecs xsee e p.lent g ifaolhntpsp selaerniatk tak t il eo avnryvntoii tiso siw ev ilt rrttlmay nbeeamrumm e

Oeuscilnvnch arcOdukol ismw otugiw,san yo sd hirimteose edeaNmtedg,i yae stt nnesil i oBearaki,r hfoeeth mkpeuflzi’troda ps itevbhmneolrvamlnos did. oe tn d lhtreeflLr itetr,ae m tsle esta g e brmae e yvneddgofy iosta eat aie wr e scoyolelNi,gi.p eroh aaig d srr ae’lasrolundse-.epets o osnoid ttcotdgupee,umrlmamieoaWnlshptn cegli.petl iatorown’aponl ifslsrmsn r ysd h ’llaese teta fun tenb osao hs

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In